- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02306707
Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach (OERS)
June 28, 2023 updated by: Professor Michael Bourke
Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach.
A patient referred to have a lesion in the stomach removed.
The aims of this study are to collect information on the technique of endoscopic removal of such lesions.
By collecting information on a large number of patients undergoing this procedure the investigators can determine the best ways of diagnosing and removing these lesions safely and effectively.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kathleen Goodrick, BN
- Phone Number: 59779 98455555
- Email: kathleen.goodrick@health.nsw.gov.au
Study Contact Backup
- Name: Farzan F Bahin, MBBS
- Phone Number: 56700 98455555
- Email: farzan.fahrtash@sydney.edu.au
Study Locations
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2145
- Recruiting
- Westmead Hospital Endoscopy Unit
-
Contact:
- Kathleen Goodrick, BN
- Phone Number: 59779 98455555
- Email: kathleen.goodrick@health.nsw.gov.au
-
Contact:
- Michael J Bourke, BN
- Phone Number: 56700 98455555
- Email: westmeadendoscopyresearch@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients who have stomach adenomas which are amendable to Endoscopic Mucosal Resection
Description
Inclusion Criteria:
- Stomach lesion > 10mm
- Lesion limited to the mucosal and/or submucosal layer (T1 lesion)
- Aged 18 years or older
Exclusion Criteria:
- Lesion less than 10mm
- Stomach lesion involves the muscularis propria (T2 lesion) on other staging modalities such as endoscopic ultrasonography (EUS)
- Aged younger than 18 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Endoscopic Mucosal Resection
Patients who are referred for Endoscopic Mucosal Resection of Stomach Lesions will be included in this cohort.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Observed procedural data: Number of Participants with Adverse Events as a Measure of Safety and Tolerability Outcomes
Time Frame: 14 days
|
14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Analysis of the costs of this procedure compared to previous treatments
Time Frame: 14 days
|
Perform cost-utility analyses comparing different treatment approaches for stomach lesions
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael J Bourke, MBBS, Western Sydney Local Health District
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
April 1, 2027
Study Registration Dates
First Submitted
December 1, 2014
First Submitted That Met QC Criteria
December 2, 2014
First Posted (Estimated)
December 3, 2014
Study Record Updates
Last Update Posted (Actual)
June 29, 2023
Last Update Submitted That Met QC Criteria
June 28, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HREC2014/5/4.1 (3970)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adenoma, Villous
-
Martin-Luther-Universität Halle-WittenbergUniversity of Ulm; Deutsche Krebshilfe e.V., Bonn (Germany); KKS NetzwerkCompletedColorectal Serrated Adenomas | Colorectal Tubular Adenomas | Colorectal Villous Adenomas | Colorectal Tubulovillous AdenomasGermany
-
Professor Michael BourkeRecruiting
-
Professor Michael BourkeRecruitingAdenoma, VillousAustralia
-
London North West Healthcare NHS TrustCompletedAdenoma Colon | Serrated AdenomaUnited Kingdom
-
Mansoura UniversityWithdrawn
-
Fondazione Poliambulanza Istituto OspedalieroCompletedAdenoma Colon | Colonic AdenomaItaly
-
National Cancer Institute (NCI)Active, not recruitingColorectal Adenoma | Colorectal Adenoma With Severe Dysplasia | Colorectal Tubulovillous AdenomaUnited States, Puerto Rico
-
Alexandra Hospital, Athens, GreeceCompletedColonoscopy | Adenoma Detection Rate | Adenoma Miss Rate | RetroflexionGreece
-
Hospital Sirio-LibanesCompletedColorectal Cancer | Colonoscopy | Adenoma Detection Rate | Adenoma Colon | Colorectal Polyp | Sessile Serrated Adenoma | Quality IndicatorBrazil
-
Azienda Unità Sanitaria Locale della RomagnaRecruitingAmpulla of Vater Adenoma | Ampullary Cancer | Ampulla of Vater Cancer | Ampullary AdenomaItaly
Clinical Trials on Endoscopic Mucosal Resection
-
Instituto do Cancer do Estado de São PauloUniversity of Sao PauloCompletedColorectal Neoplasms | AdenomaBrazil
-
Professor Michael BourkeRecruiting
-
Medical University of ViennaCompletedBarrett's Mucosa With High Grade Intraepithelial Neoplasia (HGIEN)Austria
-
Professor Michael BourkeRecruitingAdenoma, VillousAustralia
-
Professor Michael BourkeCompletedColonic PolypsAustralia
-
Massachusetts General HospitalUnknownChronic Constipation | Hirschsprung's DiseaseUnited States
-
University of British ColumbiaRecruitingColon Adenoma | Colon Polyp | Colon LesionCanada
-
Chonnam National University HospitalWithdrawnColonic PolypsKorea, Republic of
-
Massachusetts General HospitalCompletedConstipation | Hirschsprung DiseaseUnited States
-
UMC UtrechtComprehensive Cancer Centre The NetherlandsUnknownColorectal NeoplasmsNetherlands